Related Experiment Video
Updated: Jun 8, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Manifestations of chronic hepatitis C virus infection beyond the liver
Ira M Jacobson1, Patrice Cacoub, Luigino Dal Maso
1Center for the Study of Hepatitis C, Joan and Sanford I. Weill Medical College of Cornell University, New York, New York 10021, USA. imj2001@med.cornell.edu
Insights
Chronic hepatitis C virus (HCV) infection impacts multiple organ systems beyond the liver, causing serious extrahepatic manifestations. Effective anti-HCV therapy can improve some of these conditions and quality of life.
Area of Science:
- Hepatology
- Immunology
- Infectious Diseases
Background:
- Chronic hepatitis C virus (HCV) infection is primarily known for liver disease but also significantly affects other organ systems.
- Extrahepatic manifestations (EHMs) of HCV are diverse, including autoimmune conditions, metabolic disorders, and neurological impairments, reducing patient quality of life.
- These EHMs increase the complexity and cost of managing HCV infection.
Purpose of the Study:
- To review the spectrum of extrahepatic manifestations associated with chronic hepatitis C virus infection.
- To discuss the impact of these manifestations on patient quality of life and disease management.
- To highlight the role of HCV in the pathogenesis of certain EHMs and the potential benefits of anti-HCV therapy.
Main Methods:
- Literature review of studies investigating extrahepatic manifestations of hepatitis C virus.
- Analysis of clinical data on the impact of HCV on various organ systems and quality of life.
- Evaluation of treatment outcomes for HCV and its associated extrahepatic conditions.
Main Results:
- HCV infection is linked to mixed cryoglobulinemia vasculitis, lymphoproliferative disorders, renal disease, insulin resistance, type 2 diabetes, sicca syndrome, and rheumatoid arthritis-like polyarthritis.
- Quality of life is diminished by fatigue, depression, and cognitive impairment in HCV patients.
- Mixed cryoglobulinemia vasculitis, certain lymphomas, insulin resistance, and cognitive dysfunction show improvement with anti-HCV therapy.
Conclusions:
- Hepatitis C virus plays a role in the pathogenesis of specific extrahepatic manifestations like mixed cryoglobulinemia vasculitis, certain lymphomas, and insulin resistance.
- Anti-HCV therapy can positively impact certain extrahepatic manifestations and improve cognitive function and quality of life.
- Awareness of potential extrahepatic manifestations is crucial for clinicians to effectively manage patients with HCV infection.
Abstract:
In addition to its effects in the liver, chronic hepatitis C virus (HCV) infection can have serious consequences for other organ systems. Extrahepatic manifestations include mixed cryoglobulinemia (MC) vasculitis, lymphoproliferative disorders, renal disease, insulin resistance, type 2 diabetes, sicca syndrome, rheumatoid arthritis-like polyarthritis, and autoantibody production; reductions in quality of life involve fatigue, depression, and cognitive impairment. MC vasculitis, certain types of lymphoma, insulin resistance, and cognitive function appear to respond to anti-HCV therapy. However, treatments for HCV and other biopsychosocial factors can reduce quality of life and complicate management. HCV treatment has a high overall cost that increases when extrahepatic manifestations are considered. HCV appears to have a role in the pathogenesis of MC vasculitis, certain types of lymphoma, and insulin resistance. Clinicians who treat patients with HCV infections should be aware of potential extrahepatic manifestations and how these can impact and alter management of their patients.
Related Concept Videos
Cirrhosis I: Introduction
Hepatitis
Viral Hepatitis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Kidney Disease II: Clinical Manifestations
Cirrhosis II: Pathophysiology

